Self-defining Memories in Patients With a TBI (IDENTITY)

Self-defining Memories in Patients With a TBI and Their Relationships With Cognitive, Emotional and Behavioural Dimensions

The study will be conducted over 18 months. The main objective of this study is to explore the relationships between autobiographical memory and specific cognitive measures, as well as emotional and behavioural measures in patients who have suffered a moderate to severe TBI. Secondary objectives are to assess the psychometric properties of a self-defining memories questionnaire and to characterize autobiographical memory in the TBI population.

Study Overview

Detailed Description

A total of 40 participants (20 non-consecutive adults with a moderate or severe TBI and 20 volunteers with any history of neurological or psychiatric disease) will be recruited into the study. The duration of the protocol is 70 minutes. As regards the assessment, three questionnaires will be administered in order to evaluate self-defining memories, apathetic manifestations and anxio-depressive symptoms. In addition, four cognitive measures will be used to assess verbal episodic memory, working memory, cognitive flexibility and verbal fluency.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ile De France
      • Garches, Ile De France, France, 92380
        • Hopital Raymond Poincare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with a moderate or severe TBI occurred at least 6 months ago (initial Glasgow Coma Scale score ≤ 12 or post-traumatic amnesia duration > 1 week)
  • patients ≥ 18 years old and who have signed a letter of information

Exclusion Criteria:

  • history of neurological and/or psychiatric disease
  • persistent motor, sensitive and instrumental disorders that could disturb the efficient evaluation of the participant
  • patients who refused to participate in the study
  • non affiliation to a social security scheme
  • patients under guardianship or trusteeship
  • pregnant woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: cognitive measures and questionnaires
the material of the study will consist of cognitive measures and questionnaires in order to (1) compare the cognitive performances and behavioral manifestations between patients with TBI and volunteers without neurological disorders and (2) to analyze the links between cognitive and behavioural measures in the TBI population

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-defining memory score
Time Frame: 20 minutes
self-defining memories will be measured using the self-defining memories questionnaire
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
verbal episodic memory score
Time Frame: 20 minutes
verbal episodic memory will be measured using the California Verbal Learning Test
20 minutes
working memory score
Time Frame: 10 minutes
working memory will be measured using verbal span task
10 minutes
cognitive flexibility score
Time Frame: 5 minutes
cognitive flexibility will be measured using the Trail Making Test
5 minutes
verbal fluency score
Time Frame: 5 minutes
verbal fluency will be measured using the verbal fluency task
5 minutes
apathy score
Time Frame: 5 minutes
apathetic manifestations will be measured using the Apathy Evaluation Scale
5 minutes
anxio-depressive score
Time Frame: 5 minutes
anxio-depressive symptoms will be measured using the Hospital Anxiety and Depression Scale
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Annabelle Arnould, psychologue, Hopital Raymond Poincare

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2016

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

January 29, 2016

First Submitted That Met QC Criteria

February 8, 2016

First Posted (Estimate)

February 11, 2016

Study Record Updates

Last Update Posted (Actual)

May 13, 2019

Last Update Submitted That Met QC Criteria

May 9, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurobehavioral Manifestations

Clinical Trials on Questionnaires and cognitive measures

Subscribe